Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Midatech Expects 16% Half-Year Revenue Increase Amid Confident Outlook
LONDON (Alliance News) - Midatech Pharma PLC said Wednesday it expects to meet market expectations for 2018 after increasing half-year revenue year-on-year.
For the six months to June 30, the pharmaceutical company said it expects gross product revenue of GBP5.8 million, a 16% increase on the GBP5.0 million reported for the same period last year.
The company added that two of its clinical trials for its key oncology drug candidates continue to progress well.
Midatech shares were trading down 1.8% at 28.00 pence each.
Shares in this article
Latest News
- Andy Burnham to give speech on economy after Starmer resignation
2 hours ago - City mayors from London to Melbourne seek to curb data centre burden on power, water
3 hours ago - Britain will have enough electricity this winter, grid operator says
3 hours ago - US close: Stocks mixed on tech weakness, SpaceX and Alphabet drop
4 hours ago - Trump criticizes UK's Starmer after resignation announcement
4 hours ago - UK considers forcing social media firms to prioritise trusted news
4 hours ago - BP, Marathon, 7-Eleven, Walmart sued for allegedly using AI to boost California gas prices
5 hours ago
Related News
IN BRIEF: Midatech Pharma delisting and name change approved
Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutio...
Faron Pharmaceuticals
Midatech Pharma shares up as closed USD6.0 million private placement
(Alliance News) - Midatech Pharma PLC on Wednesday said it has raised USD6.0 million through a private placement of 10.3 million shares at USD0.58 eac...
Follow the stocks
